Amanote Research
Register
Sign In
MA26.05 Comprehensive Analysis of Treatment Response and Progression Pattern in Chinese Patients With Different ALK Fusion-Variants
Journal of Thoracic Oncology
- United States
doi 10.1016/j.jtho.2018.08.541
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Oncology
Respiratory Medicine
Pulmonary
Date
October 1, 2018
Authors
M. Qiao
C. Zhao
X. Li
T. Jiang
F. Wu
X. Chen
C. Su
C. Zhou
Publisher
Elsevier BV
Related search
Differential Crizotinib Response Duration Among ALK Fusion Variants in ALK-Positive Non–Small-Cell Lung Cancer
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Carcinoma of Unknown Primary With EML4‐ALK Fusion Response to ALK Inhibitors
Oncologist
Cancer Research
Medicine
Oncology
Variable Response to ALK Inhibitors in NSCLC With a Novel MYT1L-ALK Fusion
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P1.13-08 Distribution, Differences in Clinical Characteristics and Resistance Mechanism of ALK Variants in Chinese Lung Cancer Patients
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Genotypic Characteristics of Chinese Patients With BHD Syndrome and Functional Analysis of FLCN Variants
Orphanet Journal of Rare Diseases
Medicine
Genetics
Pharmacology
P07 Preliminary Orthogonal Analysis of EML4-ALK Gene Fusion Detection Methods in Chilean Patients With Lung Adenocarcinoma
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
A Novel EML6-ALK FBXO11-ALK Double Fusion Variant in Lung Adenocarcinoma and Response to Crizotinib
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P115 Clinical Outcome of Crizotinib in Diverse ALK Fusion Partners and Different Detection Methods Treatment Naïve Advanced NSCLC
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Alk Expression Plays Different Roles in Anaplastic Large-Cell Lymphomas and Outcome of Crizotinib Use in Relapsed/Refractory Alk+ Patients in a Chinese Population
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology